Skip to main content
BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.880
+0.010 (0.35%)
Apr 25, 2025, 4:00 PM EDT - Market closed

BioNexus Gene Lab Revenue

In the year 2024, BioNexus Gene Lab had annual revenue of $9.51M, down -2.66%. BioNexus Gene Lab had revenue of $2.52M in the quarter ending December 31, 2024, with 11.03% growth.

Revenue (ttm)
$9.51M
Revenue Growth
-2.66%
P/S Ratio
0.54
Revenue / Employee
$317,022
Employees
30
Market Cap
5.17M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.51M-260.16K-2.66%
Dec 31, 20239.77M-1.16M-10.60%
Dec 31, 202210.93M-2.43M-18.21%
Dec 31, 202113.36M1.97M17.31%
Dec 31, 202011.39M11.26M8,872.03%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BHP Group 53.97B
Rio Tinto Group 53.66B
CRH plc 35.57B
Linde 33.01B
Freeport-McMoRan 24.86B
The Sherwin-Williams Company 23.10B
Newmont 19.67B
Ecolab 15.74B
Revenue Rankings

BGLC News

More News